Milestone Scientific Gains Approval for Federal Supply Schedule

Milestone Scientific's Key Approval for CompuFlo® System

Milestone Scientific Inc. (MLSS), a prominent name in the medical technology industry, has recently achieved a significant milestone by securing approval for the Federal Supply Schedule (FSS) concerning its CompuFlo® Epidural System. This news marks a substantial step for the company, which specializes in developing cutting-edge computerized drug delivery instruments designed to deliver painless and precise injections. The FSS approval provides Milestone with pre-negotiated pricing and a premium position as a pre-vetted contractor, enhancing its ability to provide federal agencies with innovative medical solutions.

Understanding the Federal Supply Schedule

The FSS, commonly referred to as the GSA Schedule, is a vital procurement tool utilized by various government agencies. By being included in this schedule, Milestone Scientific can facilitate streamlined purchasing processes for its products, specifically the CompuFlo® Epidural System and its associated consumables. The initial phase of the FSS contract extends over a five-year term, with the potential to be renewed for additional five-year intervals, creating a pathway for up to 20 years of access to government buyers.

Innovative Technology at Work

The CompuFlo® Epidural System employs Milestone's proprietary Dynamic Pressure Sensing Technology, which provides real-time feedback during epidural procedures. This innovative solution is engineered to ensure precise needle placement, significantly elevating patient safety and comfort levels. By reducing complications associated with traditional epidural techniques, Milestone is setting a new standard in pain management and procedural efficacy.

Expanding Opportunities in Federal Healthcare

With the FSS contract now in place, Milestone Scientific stands poised to expand its reach into key segments of the federal healthcare market. This includes major federal healthcare providers such as the Department of Defense (DoD), the Department of Veterans Affairs (VA), and the Indian Health Service (IHS).

Targeting the Veterans Health Administration

The Veterans Health Administration operates the largest integrated healthcare system in the United States, addressing the needs of nearly 9.1 million enrolled veterans. Given that a significant portion of these veterans struggle with chronic pain, the deployment of the CompuFlo® Epidural System could play a pivotal role in enhancing their care and comfort.

Impacts on the Department of Defense

The Military Health System (MHS) under the DoD serves around 9.5 million beneficiaries, including active military personnel and their families. With a substantial percentage experiencing chronic pain, there is a crucial demand for effective pain management solutions, making Milestone's offerings timely and valuable.

Reaching American Indian Communities via the IHS

The Indian Health Service offers healthcare to 2.8 million American Indians and Alaska Natives. Many individuals receiving care through this system experience chronic pain, demonstrating the necessity for effective pain relief technologies like the CompuFlo® Epidural System.

Leadership Insight from Milestone Scientific

Arjan Haverhals, CEO of Milestone Scientific, expressed optimism regarding this federal contract. He stated, "Securing approval on the Federal Supply Schedule is pivotal for our vision to transform epidural procedures. Our technology not only demonstrates clinical efficacy but also stands as a gateway to becoming a committed partner for federal healthcare systems. This will allow us to improve patient access to our groundbreaking solutions." We have invested considerable effort into preparing for this milestone, focusing on building partnerships and a robust pipeline of opportunities within the VA, DoD, and IHS. With this approval now granted, our team is ready to collaborate with key stakeholders to foster adoption of the CompuFlo® Epidural System and enhance patient experiences across these vital healthcare sectors." Haverhals also acknowledged the crucial support received from Kandu Supplies and Services LLC and Shamrock Medical LLC, who facilitated the achievement of this important milestone.

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a technology-driven medical R&D firm that specializes in developing innovative injection technologies and medical instruments. Their focus lies on ensuring that injections are not only precise and efficient but also prioritize patient comfort and safety. With their cutting-edge computer-controlled systems, Milestone Scientific is advancing the future of medical injections. Their proprietary Dynamic Pressure Sensing Technology serves as a foundation for developing next-gen devices aimed at enhancing drug delivery methods.

Frequently Asked Questions

What is the significance of the FSS approval for Milestone Scientific?

The FSS approval allows Milestone Scientific to sell its CompuFlo® Epidural System to government agencies with pre-negotiated pricing, significantly enhancing access to their products.

How does the CompuFlo® Epidural System work?

This system utilizes Dynamic Pressure Sensing Technology to provide real-time feedback during epidural procedures, ensuring accurate needle placement and improving patient safety.

What healthcare sectors can benefit from Milestone's technology?

The technology is especially beneficial to the Department of Veterans Affairs, Department of Defense, and Indian Health Service, all of which serve populations that frequently experience chronic pain.

Who is the CEO of Milestone Scientific?

The CEO of Milestone Scientific is Arjan Haverhals, who has been instrumental in guiding the company's innovative strategies.

What is the mission of Milestone Scientific?

Milestone Scientific aims to revolutionize medical injections and epidural procedures through innovative technologies that enhance the overall patient experience and safety.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.